-
Gómez-Aguado I, Rodríguez-Castejón J, Vicente-Pascual M, Rodríguez-Gascón A, Pozo-Rodríguez AD, Solinís Aspiazu MÁ
Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA
Molecules,
2020;
25
-
Gómez-Aguado I, Rodríguez-Castejón J, Vicente-Pascual M, Rodríguez-Gascón A, Solinís MÁ, Del Pozo-Rodríguez A
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Nanomaterials (Basel),
2020;
10
-
Ibar-Bariain M, Rodríguez-Gascón A, Isla A, Solinís MÁ, Canut-Blasco A
Evaluation of the adequacy of the antimicrobial therapy of invasive Haemophilus influenzae infections: A pharmacokinetic/pharmacodynamic perspective
Enfermedades Infecciosas y Microbiología Clínica,
2020;
39,
65 - 71
-
Vicente-Pascual M, Gómez-Aguado I, Rodríguez-Castejón J, Rodríguez-Gascón A, Muntoni E, Battaglia L, Del Pozo-Rodríguez A, Solinís Aspiazu MÁ
Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production
Pharmaceutics,
2020;
12
-
Barrasa H, Soraluce A, Usón E, Sainz J, Martín A, Sánchez-Izquierdo JÁ, Maynar J, Rodríguez-Gascón A, Isla A.
Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective
International Journal of Infectious Diseases,
2020;
93,
329 - 338
-
Rodríguez-Gascón A, Aguirre-Quiñonero A, Canut-Blasco A
Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective
Enfermedades Infecciosas y Microbiología Clínica,
2020;
38,
306 - 311
-
Soraluce A, Barrasa H, Asín-Prieto E, Sánchez-Izquierdo JÁ, Maynar J, Isla A, Rodríguez-Gascón A
Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation
Pharmaceutics,
2020;
12
-
del Pozo-Rodríguez A, Rodríguez-Gascón A, Rodríguez-Castejón J, Vicente-Pascual M, Gómez-Aguado I, Battaglia LS, Solinís MÁ
Gene Therapy
Advances in Biochemical Engineering / Biotechnology,
2020;
171,
321 - 368
-
Lertxundi Etxebarria U, Palacios-Zabalza I, Ibarrondo I, Domingo-Echaburu S, Hernandez R, Isla A, Solinis M.
Pharmacotherapeutic management of Parkinson's disease inpatients: how about asking hospital pharmacists?
European Journal of Hospital Pharmacy,
2020;
2020
-
Oñatibia-Astibia A, Malet-Larrea A, Gastelurrutia MÁ, Calvo B, Ramírez D, Cantero I, Goyenechea E.
Effect of health professional intervention on adherence to statin use according to the cause of patient non-adherence.
International Journal of Clinical Pharmacy,
2020;
42,
331 - 335
-
Oñatibia-Astibia A, Malet-Larrea A, Gastelurrutia MÁ, Calvo B, Goyenechea E.
Community pharmacist interventions to improve adherence to lipid lowering medication and their influence on clinical outcomes: A systematic review and meta-analysis
Journal of Evaluation on Clinical Practice,
2020
